Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.

Saved in:
Bibliographic Details
Title: Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.
Authors: Lucas CG; Department of Pathology, University of California, San Francisco, CA., Villanueva-Meyer JE; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA., Whipple N; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT., Oberheim Bush NA; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, CA.; Department of Neurology, University of California, San Francisco, CA., Cooney T; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, CA., Chang S; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, CA.; Department of Neurology, University of California, San Francisco, CA., McDermott M; Department of Neurological Surgery, University of California, San Francisco, CA., Berger M; Department of Neurological Surgery, University of California, San Francisco, CA., Cham E; Department of Pathology, UCSF Benioff Children's Hospital Oakland, Oakland, CA., Sun PP; Department of Neurosurgery, UCSF Benioff Children's Hospital Oakland, Oakland, CA., Putnam A; Department of Pathology, University of Utah, Salt Lake City, UT., Zhou H; Department of Pathology, University of Utah, Salt Lake City, UT., Bollo R; Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City, UT., Cheshier S; Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City, UT., Poppe MM; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Fung KM; Department of Pathology, University of Oklahoma, Oklahoma City, OK., Sung S; Department of Neurology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK., Glenn C; Department of Neurosurgery, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK., Fan X; Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA., Bannykh S; Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA., Hu J; Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA., Danielpour M; Department of Neurosurgery, Cedars Sinai Medical Center, Los Angeles, CA., Li R; Department of Pathology, Children's Hospital of Alabama, Birmingham, AL., Alva E; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Children's Hospital of Alabama, Birmingham, AL., Johnston J; Department of Neurosurgery, Children's Hospital of Alabama, Birmingham, AL., Van Ziffle J; Department of Pathology, University of California, San Francisco, CA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA., Onodera C; Department of Pathology, University of California, San Francisco, CA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA., Devine P; Department of Pathology, University of California, San Francisco, CA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA., Grenert JP; Department of Pathology, University of California, San Francisco, CA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA., Lee JC; Department of Pathology, University of California, San Francisco, CA., Pekmezci M; Department of Pathology, University of California, San Francisco, CA., Tihan T; Department of Pathology, University of California, San Francisco, CA., Bollen AW; Department of Pathology, University of California, San Francisco, CA., Perry A; Department of Pathology, University of California, San Francisco, CA.; Department of Neurological Surgery, University of California, San Francisco, CA., Solomon DA; Department of Pathology, University of California, San Francisco, CA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, CA.
Source: Brain pathology (Zurich, Switzerland) [Brain Pathol] 2020 May; Vol. 30 (3), pp. 479-494. Date of Electronic Publication: 2019 Nov 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: International Society of Neuropathology Country of Publication: Switzerland NLM ID: 9216781 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-3639 (Electronic) Linking ISSN: 10156305 NLM ISO Abbreviation: Brain Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first